These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 23451128

  • 41. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.
    Guo Y, Zhang X, Meng J, Wang ZY.
    Eur J Pharmacol; 2011 May 11; 658(2-3):114-22. PubMed ID: 21376032
    [Abstract] [Full Text] [Related]

  • 42. 8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers.
    Polotskaia A, Hoffman S, Krett NL, Shanmugam M, Rosen ST, Bargonetti J.
    Mol Cancer Ther; 2012 Nov 11; 11(11):2495-504. PubMed ID: 22973058
    [Abstract] [Full Text] [Related]

  • 43. Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ER.
    Zulehner N, Maurer M, Wesierska-Gadek J.
    J Exp Ther Oncol; 2011 Nov 11; 9(1):17-25. PubMed ID: 21275262
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The anti-cancer activities of Vernonia amygdalina extract in human breast cancer cell lines are mediated through caspase-dependent and p53-independent pathways.
    Wong FC, Woo CC, Hsu A, Tan BK.
    PLoS One; 2013 Nov 11; 8(10):e78021. PubMed ID: 24205071
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.
    Węsierska-Gądek J, Gritsch D, Zulehner N, Komina O, Maurer M.
    J Cell Biochem; 2011 Mar 11; 112(3):761-72. PubMed ID: 21328450
    [Abstract] [Full Text] [Related]

  • 49. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
    Hahm ER, Lee J, Huang Y, Singh SV.
    Mol Carcinog; 2011 Aug 11; 50(8):614-24. PubMed ID: 21432907
    [Abstract] [Full Text] [Related]

  • 50. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
    Jiang C, Guo J, Wang Z, Xiao B, Lee HJ, Lee EO, Kim SH, Lu J.
    Breast Cancer Res; 2007 Aug 11; 9(6):R77. PubMed ID: 17986353
    [Abstract] [Full Text] [Related]

  • 51. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
    Xian M, Ito K, Nakazato T, Shimizu T, Chen CK, Yamato K, Murakami A, Ohigashi H, Ikeda Y, Kizaki M.
    Cancer Sci; 2007 Jan 11; 98(1):118-26. PubMed ID: 17129359
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
    Chen JS, Lin SY, Tso WL, Yeh GC, Lee WS, Tseng H, Chen LC, Ho YS.
    Mol Carcinog; 2006 Jul 11; 45(7):461-78. PubMed ID: 16649252
    [Abstract] [Full Text] [Related]

  • 54. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
    Huang MB, Gonzalez RR, Lillard J, Bond VC.
    Oncotarget; 2017 Feb 14; 8(7):11302-11315. PubMed ID: 28076321
    [Abstract] [Full Text] [Related]

  • 55. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM, Akhtar MN, Ky H, Lim KL, Abu N, Zareen S, Ho WY, Alan-Ong HK, Tan SW, Alitheen NB, Ismail JB, Yeap SK, Kamarul T.
    Drug Des Devel Ther; 2016 Feb 14; 10():1897-907. PubMed ID: 27358555
    [Abstract] [Full Text] [Related]

  • 56. A Novel Polyhalogenated Monoterpene Induces Cell Cycle Arrest and Apoptosis in Breast Cancer Cells.
    El Gaafary M, Hafner S, Lang SJ, Jin L, Sabry OM, Vogel CV, Vanderwal CD, Syrovets T, Simmet T.
    Mar Drugs; 2019 Jul 25; 17(8):. PubMed ID: 31349625
    [Abstract] [Full Text] [Related]

  • 57. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53.
    Ho TF, Ma CJ, Lu CH, Tsai YT, Wei YH, Chang JS, Lai JK, Cheuh PJ, Yeh CT, Tang PC, Tsai Chang J, Ko JL, Liu FS, Yen HE, Chang CC.
    Toxicol Appl Pharmacol; 2007 Dec 15; 225(3):318-28. PubMed ID: 17881028
    [Abstract] [Full Text] [Related]

  • 58. NOAD, a novel nitric oxide donor, induces G2/M phase arrest and apoptosis in human hepatocellular carcinoma Bel-7402 cells.
    Liu L, Wang D, Wang J, Ji H, Zhang Y.
    Toxicol In Vitro; 2015 Oct 15; 29(7):1289-97. PubMed ID: 26001517
    [Abstract] [Full Text] [Related]

  • 59. Centaurea cyanus extracted 13-O-acetylsolstitialin A decrease Bax/Bcl-2 ratio and expression of cyclin D1/Cdk-4 to induce apoptosis and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.
    Keyvanloo Shahrestanaki M, Bagheri M, Ghanadian M, Aghaei M, Jafari SM.
    J Cell Biochem; 2019 Oct 15; 120(10):18309-18319. PubMed ID: 31161672
    [Abstract] [Full Text] [Related]

  • 60. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS, Liu W, Wang XB, Lu N, Gong DD, Kong LY, Guo QL.
    Anticancer Drugs; 2011 Jan 15; 22(1):46-57. PubMed ID: 20948430
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.